Key result
High-flux hemodialysis decreased NT-proBNP, BNP, and TnT levels, whereas low-flux hemodialysis increased NT-proBNP and TnT levels.
Why the study?
Does hemodialysis with a high-flux membrane compared to a low-flux membrane affect plasma levels of cardiac biomarkers in hemodialysis patients?
RCT (n=31)
Crossover
Does hemodialysis with a high-flux membrane compared to a low-flux membrane affect plasma levels of cardiac biomarkers in hemodialysis patients?
High-flux hemodialysis significantly reduces plasma levels of cardiac biomarkers (BNP, NT-proBNP, TnT), which could potentially mask acute cardiac events like myocardial infarction.
Answers are grounded in this paper and cite their sources.
High-flux hemodialysis may mask acute cardiac events by lowering biomarkers; extends evidence on membrane flux effects in dialysis patients.
BACKGROUND: Brain natriuretic peptide (BNP), N-terminal-proBNP (NT-proBNP), and high sensitive cardiac troponin T (TnT) are markers that are elevated in chronic kidney disease and correlate with increased risk of mortality. Data are conflicting on the effect of biomarker levels by hemodialysis (HD).Our aim was to clarify to what extent HD with low-flux (LF) versus high-flux (HF) membranes affects the plasma levels of BNP, NT-proBNP, and TnT. METHODS AND MATERIALS: 31 HD patients were included in a crossover design, randomized to start dialysis with a LF-HD or HF-HD dialyzer. Each patient was his/her own control. The dialyses included in the study were the first treatments of two consecutive weeks with each mode of dialysis. Patients normally on hemodiafiltration (HDF) also performed a HDF the third week. Values after HD were corrected for extent of ultrafiltration. RESULTS: During LF-HD the biomarkers NT-proBNP and TnT increased (15 versus 6%, P ≤ .001) while there was a slight decrease in BNP (P<.05). During HF-HD the NT-proBNP, BNP and TnT levels decreased (P ≤ .01 for all). During HDF all three markers decreased (P<.01 for all). The rise in TnT during LF-HD correlated with dialysis vintage (months on HD, r = .407, P = .026), Kt/V-urea (r = .383, P = .037), HD time in hours/treatment (r = .447, P = .013) and inversely with residual urinary output (r = -.495, P = .005). The baseline levels of BNP and NT-proBNP correlated with blood pressure. CONCLUSIONS: Cardiac biomarkers increase slightly during LF-HD. A HF-HD eliminates the biomarkers and can mask increases caused by, e.g., myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Laveborn et al. (2015) conducted an RCT in Hemodialysis (n=31). High-flux (HF) hemodialysis vs. Low-flux (LF) hemodialysis was evaluated on Plasma levels of BNP, NT-proBNP, and TnT (p=≤0.01). High-flux hemodialysis decreased NT-proBNP, BNP, and TnT levels, whereas low-flux hemodialysis increased NT-proBNP and TnT levels.
Synapse has enriched 10 related papers. Consider them for comparative context: